Employer-Paid

The retail giant announced enhancements to several benefits programs, including coverage of GLP-1s for Type 2 diabetes at no cost to employees.

"Not only does this settlement hold bad actors accountable for their fraudulent activities, but Americans are safer because of it," Associate Attorney General Stanley E. Woodward Jr. said.

Hospital groups argue that paying higher drug prices before collecting rebates would strain cash flow and add more than $1 billion in annual administrative costs.

Fewer than one-third typically feel very confident when making health care decisions.

The boost will not be enough to stave off retirees' higher costs, advocacy groups say.

"What we're clearly seeing is growing demand for hyper-personalized support from employees," says Molly Beer, a retirement plan consultant at Gallagher.